Author:
Zhang Tenny R.,Basourakos Spyridon P.,Bhojani Naeem,Zorn Kevin,Elterman Dean,Chughtai Bilal
Publisher
Springer Science and Business Media LLC
Subject
Molecular Biology,Biochemistry
Reference32 articles.
1. Kellogg Parsons J. Benign prostatic hyperplasia and male lower urinary tract symptoms: epidemiology and risk factors. Curr Bladder Dysfunt Rep 1010:5(4):212–18.
2. Wallner LP, Slezak J, Loo RK, Quinn VP, Van Den Eeden SK, Jacobsen SJ. Progression and treatment of incident lower urinary tract symptoms (LUTS) among men in the California Men’s Health Study. BJU Int. 2015;115(1):127–33.
3. Welch G, Weinger K, Barry MJ. Quality-of-life impact of lower urinary tract symptom severity: results from the Health Professionals Follow-up Study. Urology. 2002;59:245–50.
4. De Nunzio C, Presicce F, Lombardo R, Trucchi A, Bellangino M, Tubaro A, Moja E. Patient centred care for the medical treatment of lower urinary tract symptoms in patients with benign prostatic obstruction: a key point to improve patients’ care—a systematic review. BMC Urol. 2018;18:62.
5. World Health Organization. Patient Engagement: Technical Series on Safer Primary Care. Geneva: World Health Organization. 2016. Accessed 4 Apr 2021 at https://apps.who.int/iris/bitstream/handle/10665/252269/9789241511629-eng.pdf.